[Histonet] Announcing the 12th annual retreat of applied immunohistochemistry and molecular pathology at the beautiful Marriott, Key Largo, FL
Richard.Cartun at hhchealth.org
Sat Oct 7 19:12:47 CDT 2017
I am forwarding this exciting meeting announcement to the Histonet Community.
Richard W. Cartun, MS, PhD
Director, Histology & The Martin M. Berman, MD Immunopathology & Morphologic Proteomics Laboratory
Director, Biospecimen Collection Programs
Assistant Director, Anatomic Pathology
80 Seymour Street
Hartford, CT 06102
(860) 545-2204 Fax
Following pre-hurricane preparation and 2 weeks of lack of electricity post-hurricane, we’re finally able to get our lives back on track, hence this delayed announcement for the 12th annual AIMP retreat. Please forward this email to as many folks as you can. Those of you who attended previous retreats will receive a decent discount as specified on the website.
Please let me know if you have any questions. I hope to see you in the FL Keyes in February.
Hadi Yaziji, MD, FCAP, FASCP
Vitro Molecular Laboratories
8700 W. Flagler Street, Suite 100 l Miami, FL 33174
hyaziji at vitromolecular.com<mailto:hyaziji at vitromolecular.com>
Office 305-267-7979 l Fax 786-513-0175
12th Annual International Retreat on Applied Immunohistochemistry & Molecular Pathology
Previous AIMP retreat attendees have attested that AIMP has been “the best pathology CME event ever attended”. Our 12th annual retreat will have the following list of speakers (arranged alphabetically):
Noah Brown, MD; University of Michigan
Richard Cartun, PhD; Hartford Hospital
Carol Cheung, MD, PhD., JD, FRCPC, University of Toronto
Brenda Cox, FHFMA, CPC, MT (ASCP)
Richard Eisen, MD; Banner Health
Joel Greenson, MD; University of Michigan
Jason Hornick, MD, PhD; Harvard University
Jeffrey Myers, MD; University of Michigan
Emina Terlacovich, MD, PhD; University of Saskatchewan
Megan Troxell, MD; Stanford University
Hadi Yaziji, MD, Vitro Molecular Laboratories
Location: Key Largo Marriott (Key Largo, FL, USA)
Date: February 4 - February 8, 2018
Topics at a glance:
Sunday, February 4
Welcome and Opening Remarks [Hadi Yaziji]
Pre-Test [Hadi Yaziji]
Interpreting FISH Assays by The Practicing Pathologist - General Principles [Hadi Yaziji]
Best of USCAP 2017: IHC Applications [Richard Eisen]
Developing Fit-For-Purpose IHC Assays [Carol Cheung]
Validation vs. Verification of IHC Assays: The Clue is in the Test Performance Characteristics [Emina Torlakovic]
Tissue Tools are Power Tools for the IHC Laboratory. [Carol Cheung]
Controlling the Controls in IHC – a Path to Standardization [Emina Torlakovic]
Monday, February 5:
Malignant Mesothelioma and Other Diffuse Pleural Tumors [Jeffrey Myers]
Role of the Pathologist in Diagnosis and Management of Patients with NSCLC [Jeffrey Myers]
Interpreting FISH Assays: Common Assays & Specific Scenarios [Hadi Yaziji]
Molecular Genetics of Colon Cancer, what a practicing surgical pathologist needs to know [Joel Greenson]
Specimen Considerations for Solid Tumor Molecular Testing [Noah Brown]
PD-L1: Interpretation Pitfalls & Update on Utility as a Companion Diagnostic Assay [Hadi Yaziji]
Tuesday, February 6:
HER2 Testing: 2018 ASCO/CAP Guidelines - What’s New and Why [Hadi Yaziji]
Troubleshooting Diagnostic Immunohistochemistry [Rich Cartun]
Open Mic: Bring Your Own Questions - Part I [Hadi Yaziji]
Best “Specialized” Markers (Myoepithelial, Cytokeratins, Neuroendocrine, Endothelial, Histocytic, Megakaryocitic, Erythroid, ETC) in IHC [Hadi Yaziji]
Surgical Pathology Case Presentations - Session 1 [Faculty]
Surgical Pathology Case Presentations - Session 2 [Faculty]
Wednesday February 7:
The Evolution of IHC for Soft Tissue Tumors in the 21st Century: From Differentiation to Molecular Genetics [Hornick]
Immunohistochemistry in Kidney Tumors: The New WHO Classification and Beyond [Megan Troxell]
Beyond Lineage: Diagnostic and Predictive Molecular IHC for Surgical Pathologists [Jason Hornick]
Immunohistochemistry in Transplant Pathology [Megan Troxell]
Surgical Pathology Case Presentations - Session 3 [Faculty]
Surgical Pathology Case Presentations - Session 4 [Faculty]
Thursday, February 8:
Essential Coding & Compliance: 2018 Update - Part I [Brenda Cox]
Essential Coding & Compliance: 2018 Update - Part II [Brenda Cox]
Open Mic: Bring Your Own Questions - Part II [Hadi Yaziji]
Open Mic: Bring Your Own Questions - Part III [Hadi Yaziji]
Surgical Pathology Case Presentations - Session 5 [Faculty]
Surgical Pathology Case Presentations - Session 6 [Faculty]
To register for the retreat or for any other information, please visit us online at pathlearning.com<http://pathlearning.us10.list-manage.com/track/click?u=b4d3e9ff192b16fd68e3363a0&id=fbab3d3361&e=a3d20f9b8d>
For any other questions or inquiries, please email us at info at pathlearning.com<mailto:info at pathlearning.com> For complete information of venue, retreat schedule, roster of expert speakers, we invite you to visit www.pathlearning.com<http://pathlearning.us10.list-manage.com/track/click?u=b4d3e9ff192b16fd68e3363a0&id=9939798bfa&e=a3d20f9b8d>.
You received this message because you are subscribed to the Google
Groups "ihcrg" group. The IHC Resource Group is a standing committee within the National Society for Histotechnology.
To post to this group, send email to ihcrg at googlegroups.com<mailto:ihcrg at googlegroups.com>
To unsubscribe from this group, send email to
ihcrg+unsubscribe at googlegroups.com<mailto:ihcrg+unsubscribe at googlegroups.com>
For more options, visit this group at
To contact the National Society for Histotechnology, email: histo at nsh.org<mailto:histo at nsh.org> or call 443.535.4060.
You received this message because you are subscribed to the Google Groups "ihcrg" group.
To unsubscribe from this group and stop receiving emails from it, send an email to ihcrg+unsubscribe at googlegroups.com<mailto:ihcrg+unsubscribe at googlegroups.com>.
For more options, visit https://groups.google.com/d/optout.
Reminder: This e-mail and any attachments are subject to the current HHC email retention policies. Please save or store appropriately in accordance with policy.
This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, or distribution is prohibited. If you are not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message, including any attachments.
More information about the Histonet